SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

9688 (9688) News

Follow 9688 (9688) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 10 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol 9688 Asset market Sector Markets 90 days 10 Updated Nov 05, 2026, 06:16 PM UTC Open live news feed
L Zai Lab Reports Results for Quarter Ended September 30 EARNINGS | Nov 05, 2026, 06:16 PM UTC M Zai Lab Reports Third-Quarter Revenue of $108.21M and EPS Loss of $0.04 Third-quarter revenue fell 7% year over year and the net loss widened. Lower sales of ZEJULA, OPTUNE and VYVGART outweighed growth in NUZYRA and XACDURO and KarXT’s June launch; higher product costs and research and deve EQUITY | Nov 05, 2026, 11:51 AM UTC M Zai Lab Reports Third-Quarter Revenue of $108.2 Million EQUITY | Nov 05, 2026, 11:43 AM UTC M Zai Lab Reports Third-Quarter Loss per Share EQUITY | Nov 05, 2026, 11:31 AM UTC M Zai Lab Shares Rise 7.3% on Positive Phase 1 Trial Data Zai Lab said it reported positive data from a Phase 1 trial evaluating its small cell lung cancer treatment. Shares rose 7.3% in premarket trading to $23.65. EQUITY | Oct 23, 2026, 11:25 AM UTC M Zai Lab Agrees to Raise About $250 Million in Private Placement Zai Lab agreed to sell 11.34 million American depositary shares to accredited investors at $22.04 each, for expected gross proceeds of approximately $250 million. The placement is expected to close on or about October 27 EQUITY | Oct 23, 2026, 10:13 AM UTC M Zai Lab Announces $250 Million Private Placement Zai Lab entered into a securities purchase agreement to sell 11,340,000 ADSs, each representing ten ordinary shares, to investors. EQUITY | Oct 23, 2026, 12:59 AM UTC M Zai Lab to Raise $250.0M via Private Placement EQUITY | Oct 23, 2026, 12:58 AM UTC M Zai Lab Prices $250 Million PIPE at $22.04 per ADS Zai Lab will sell 11,340,000 ADSs at $22.04 each for approximately $250 million in gross proceeds. The PIPE is expected to close on or about Oct. 27, 2026, subject to customary conditions. EQUITY | Oct 23, 2026, 12:52 AM UTC L Zai Lab to Present First Global Data from Clinical Trial Evaluating Zocilurtatug Pelitecan (Zoci) As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Zai Lab Limited (NASDAQ:ZLAB; HKEX:9688) today announced that global data from a clinical trial evaluating zocilurtatug pelitecan (zoci, formerly ZL-1310) for the first-line treatment of extensive-stage small cell lung c NEWS | Sep 29, 2026, 11:01 AM UTC